MedImmune 'leaps' ahead: Wins 1st US OK of quad flu vaccine
This article was originally published in Scrip
Executive Summary
AstraZeneca unit MedImmune marked leap year on 29 February by winning approval from the US FDA of the first quadrivalent influenza vaccine in the US.